MeiraGTx Holdings (MGTX) Operating Income (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Operating Income of $26.5 million for Q4 2025, up 184.06% on a YoY basis from $9.3 million in Q4 2024, and up 157.48% quarter-over-quarter from -$46.1 million in Q3 2025.
MeiraGTx Holdings (MGTX) Operating Income (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Operating Income for 9 years, with the latest figure at $26.5 million in Q4 2025.
- For the quarter ending Q4 2025, Operating Income rose 184.06% year-over-year to $26.5 million; the trailing twelve-month figure through Dec 2025 stood at -$106.0 million (up 35.47% YoY), and the FY2025 full-year result was -$106.0 million, up 35.47% from the prior year.
- Operating Income for Q4 2025 stood at $26.5 million, up from -$46.1 million in the prior quarter.
- The five-year high for Operating Income was $26.5 million in Q4 2025, with the low at -$46.8 million in Q1 2024.
- Historically, Operating Income has averaged -$29.8 million across 5 years, with a median of -$31.6 million in 2023.
- Annual changes were most pronounced in 2022 — Operating Income plunged 433.88% — and 2025, when it jumped 184.06%.
- MeiraGTx Holdings' Operating Income stood at -$7.7 million in 2021, then sank by 433.88% to -$41.1 million in 2022, then decreased by 6.57% to -$43.8 million in 2023, then rose by 28.03% to -$31.5 million in 2024, then jumped by 184.06% to $26.5 million in 2025.
- The last three Operating Income figures came in at $26.5 million (Q4 2025), -$46.1 million (Q3 2025), and -$44.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 26.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.47 Mn |
| Sep 30, 2025 | -46.05 Mn |
| Jun 30, 2025 | -44.79 Mn |
| Mar 31, 2025 | -41.60 Mn |
| Dec 31, 2024 | -31.49 Mn |
| Sep 30, 2024 | -40.04 Mn |
| Jun 30, 2024 | -45.91 Mn |
| Mar 31, 2024 | -46.77 Mn |
| Dec 31, 2023 | -43.75 Mn |
| Sep 30, 2023 | -32.76 Mn |
| Jun 30, 2023 | -28.79 Mn |
| Mar 31, 2023 | -31.76 Mn |
| Dec 31, 2022 | -41.06 Mn |
| Sep 30, 2022 | -22.81 Mn |
| Jun 30, 2022 | -23.76 Mn |
| Mar 31, 2022 | -28.73 Mn |
| Dec 31, 2021 | -7.69 Mn |
| Sep 30, 2021 | -22.55 Mn |
| Jun 30, 2021 | -20.48 Mn |
| Mar 31, 2021 | -22.03 Mn |